MENU
+Compare
ALDX
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$3.79
Change
-$0.08 (-2.07%)
Capitalization
227M

ALDX Aldeyra Therapeutics Forecast, Technical & Fundamental Analysis

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases... Show more

Industry: #Biotechnology
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALDX with price predictions
Jun 27, 2025

Momentum Indicator for ALDX turns positive, indicating new upward trend

ALDX saw its Momentum Indicator move above the 0 level on June 04, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ALDX moved above its 50-day moving average on June 06, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ALDX crossed bullishly above the 50-day moving average on June 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ALDX advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 190 cases where ALDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALDX broke above its upper Bollinger Band on June 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.569) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). ALDX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALDX is expected to report earnings to rise 43.12% to -24 cents per share on August 08

Aldeyra Therapeutics ALDX Stock Earnings Reports
Q2'25
Est.
$-0.24
Q1'25
Beat
by $0.12
Q4'24
Missed
by $0.03
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
The last earnings report on May 01 showed earnings per share of -17 cents, beating the estimate of -28 cents. With 2.54M shares outstanding, the current market capitalization sits at 227.00M.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for eye diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
131 Hartwell Avenue
Phone
+1 781 761-4904
Employees
10
Web
https://www.aldeyra.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRDCY20.750.41
+1.99%
Bridgestone Corp.
EMNSF1.90N/A
N/A
Elementis PLC
RMGOF8.03N/A
N/A
Remgro Ltd.
SIERF0.07N/A
N/A
Sierra Grande Minerals Inc.
GENMF0.23-0.02
-7.14%
Generation Mining Limited

ALDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-2.07%
GSGTF - ALDX
56%
Loosely correlated
N/A
CGON - ALDX
39%
Loosely correlated
-0.46%
PLRX - ALDX
38%
Loosely correlated
-3.08%
ARVN - ALDX
37%
Loosely correlated
-3.14%
MGTX - ALDX
32%
Poorly correlated
-0.90%
More